 
|
 Exited Biopharmaceuticals
 Developer of novel biopharmaceutical products to treat pain and to relieve the side effects of current pain medications.
Ticker: ADLR Exton, PA  Late clinical stage biopharmaceutical company with phase 3
product candidate for the treatment of anemia associated with chronic renal
failure.
Ticker: AFFY Palo Alto, CA  Commercial stage specialty pharmaceutical company targeting connective tissue disorders and male health conditions.
Ticker: AUXL Norristown, PA  Pharmaceutical company focused on developing and commercializing products in the field of dermatology.
Ticker: BTRX Princeton, NJ  Development and commercialization of therapies for serious, life-threatening infections. Acquired by Forest Laboratories.
Alameda, CA  Life improving therapeutics for the treatment of human disease. Merged from Variagenics.
Ticker: NUVO Sunnyvale, CA  Clinical stage respiratory drug delivery and development
company focusing on medicines for asthma and pulmonary disease.
Research Triangle Park, NC  Commercial stage specialty pharmaceutical and diagnostics
company focused on gastrointestinal medicine.
Acquired by Nestlé Health Science. San Diego, CA  Site specific gene therapeutics and DNA devices for tissue repair and regeneration.
San Diego, CA  Structure guided drug discovery company accelerating the discovery of novel therapeutics to treat human diseases.
Ticker: SGXP San Diego, CA  Biopharmaceutical company focused on developing RNA interference (RNAi) based therapeutics. Acquired by Merck & Co.
Boulder, CO |
